Nobel for antimalarial drug highlights East-West divide

See allHide authors and affiliations

Science  16 Oct 2015:
Vol. 350, Issue 6258, pp. 265
DOI: 10.1126/science.350.6258.265

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The question at last week's press conference announcing the Nobel Prize in Physiology or Medicine sparked a frisson of tension in the staid Stockholm hall. Referring to the award of half of the prize to pharmacologist Youyou Tu for deriving the antimalarial drug artemisinin from a plant used in traditional Chinese medicine (TCM), a Chinese reporter asked: "Can we say this is the first time you award [recognition to] TCM?" "We are not giving a prize to traditional medicine," shot back Hans Forssberg, a member of the selection committee. Traditional medicine was a source of inspiration, he explained, but the prize was for discovering a new drug. In fact, the award exposes a widening rift between the biomedical mainstream and proponents of alternative therapies such as TCM, which is based on principles dating back 2000 years.

  • * Shanghai, China

    With reporting by Hao Xin.

View Full Text

Stay Connected to Science